无MAS的NLRC4相关自身炎症性疾病中游离IL-18升高
该研究检测了6例无巨噬细胞活化综合征(MAS)的NLRC4相关自身炎症性疾病(NLRC4-AID)患者(5例胚系p.S445P、1例体细胞p.V341L)的游离IL-18及相关细胞因子。结果显示FCAS4患者和体细胞NLRC4-AID患者的总IL-18与游离IL-18均升高,但与炎症或MAS实验室指标无相关,MAS相关细胞因子IFN-γ、CXCL9、CXCL10未升高。结论提示游离IL-18单独不足以驱动MAS,IL-18在NLRC4-AID中可能具有MAS之外的病理作用。
要点
- 无MAS的NLRC4-AID患者总IL-18和游离IL-18均升高。
- 游离IL-18与炎症或MAS实验室指标无相关。
- 仅造血系统来源的游离IL-18不足以驱动MAS。
核心结论
- 胚系和体细胞NLRC4-AID无MAS时均伴总IL-18和游离IL-18升高。
- 仅造血系统来源的游离IL-18不足以驱动MAS。
- IL-18是驱动MAS的必要但不充分因素,在NLRC4-AID中可能具有MAS之外的病理作用。
研究设计与样本
- 研究纳入5例胚系p.S445P和1例体细胞p.V341L NLRC4-AID无MAS患者。
- 获取临床、遗传和实验室数据及血清样本。
- 用基于珠的检测法测定IL-6、sCD25、CXCL9、CXCL10、IL-12p70、IFN-γ、总IL-18、IL-1β、TNF-α和IL-1Ra。
- 用专有ELISA测定游离IL-18。
主要发现
- FCAS4患者和体细胞NLRC4-AID患者的总IL-18与游离IL-18均升高。
- 总IL-18和游离IL-18与炎症或MAS实验室标志物无相关。
- 无MAS的NLRC4-AID患者中MAS相关细胞因子IFN-γ、CXCL9和CXCL10未升高。
临床怎么用
- 无MAS的NLRC4-AID患者也应关注总IL-18和游离IL-18升高。
- 游离IL-18升高不直接等同于MAS风险,需结合MAS相关细胞因子综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: NLRC4-associated autoinflammatory diseases (NLRC4-AID) cover a clinical spectrum from relatively mild familial cold autoinflammatory syndrome 4 (FCAS4) to life-threatening macrophage activation syndrome (MAS). Free IL-18 has been shown to pathogenically promote MAS, but the pathological relevance of free IL-18 in NLRC4-AID without MAS has not been explored. We investigated free IL-18 and related cytokines in five germline p.S445P and one somatic p.V341L NLRC4-AID patients without MAS. METHODS: Clinical, genetic and laboratory data, as well as serum samples were obtained from NLRC4-AID patients without MAS. Human IL-6, soluble CD25, CXCL9, CXCL10, IL-12p70, IFN-γ, total IL-18, IL-1β, TNF-α and IL-1Ra were assessed using a bead-based assay. Free IL-18 was assessed using a proprietary ELISA. RESULTS: Total and free IL-18 were elevated both in the FCAS4 patients and the NLRC4-AID patient harbouring a heterozygous somatic NLRC4 variant restricted to the haematopoietic compartment. Despite the association between free IL-18 and MAS, we found no relevant correlation between total and free IL-18 and laboratory markers of inflammation or MAS. Accordingly, MAS-associated cytokines IFN-γ, CXCL9 and CXCL10 were not elevated in NLRC4-AID patients without MAS. CONCLUSION: Germline and somatic NLRC4-AID without MAS are associated with elevated levels of both total and free IL-18. Our findings in the somatic NLRC4-AID patient suggest that free IL-18 originating from the haematopoietic system alone is not sufficient to drive MAS. Our findings indicate that IL-18 is necessary but not sufficient to drive MAS and suggest a pathological role of IL-18 beyond MAS in NLRC4-AID.
引用
- Willemsen M, Schoonbrood THM, Rodriguez E, et al. Free IL-18 in NLRC4-associated autoinflammatory disease without macrophage activation syndrome. Rheumatology (Oxford). 2026. PMID: 42444142. doi:10.1093/rheumatology/keag363
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。